Section 49-20-419 - Coverage of exome sequence testing(1) As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.(2) Beginning July 1, 2019, the program shall provide coverage for exome sequence testing: (a) for a covered individual within the state risk pool who:(i) is younger than 21 years of age; and(ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related tests;(b) performed by a nationally recognized provider with significant experience in exome sequence testing;(c) that is medically necessary; and(d) at a rate set by the program.Added by Chapter 320, 2019 General Session ,§ 2, eff. 5/14/2019.